GlassScriptPhysician profile
Charles Mason
NPI 1073935425
$18,583.81
in general payments reported to CMS, 2019-2025
55 companies · $4,302 in 2025
The $4,302 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,034 · 2022: $2,233 · 2023: $3,895 · 2024: $4,119 · 2025: $4,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,315.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,646.34 | 2021-2025 | |
| Novo Nordisk INC | $2,556.11 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,832.45 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $1,681.79 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $904.56 | 2021-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $823.07 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $694.38 | 2021-2025 | Trintellix, Glassia |
| Pfizer INC. | $610.57 | 2021-2025 | |
| Abbott Laboratories | $569.53 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $563.87 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Biohaven Pharmaceuticals, INC. | $538.60 | 2021 | |
| Bausch Health US, LLC | $497.98 | 2021-2025 | Aplenzin |
| Amarin Pharma, INC. | $460.19 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $363.20 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Phathom Pharmaceuticals, INC. | $330.91 | 2024-2025 | Voquezna |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $272.41 | 2024-2025 | Symbravo, Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.62 | 2022-2025 | Jardiance, Synjardy |
| Daiichi Sankyo INC. | $267.04 | 2021-2024 | Injectafer |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $254.73 | 2023-2025 | Caplyta |
| Upsher-Smith Laboratories LLC | $204.91 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $172.27 | 2021 | |
| Janssen Pharmaceuticals, INC | $142.79 | 2021-2025 | Spravato |
| Sanofi-Aventis U.S. LLC | $132.18 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $121.63 | 2021-2025 | Gardasil 9, Capvaxive, Lagevrio |
| Xeris Pharmaceuticals, INC. | $120.58 | 2022-2025 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $117.03 | 2022 | |
| Exact Sciences Corporation | $115.87 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $98.89 | 2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $96.70 | 2021-2024 | Livalo, Zoryve |
| Antares Pharma, INC. | $95.98 | 2024-2025 | Xyosted |
| Hikma Pharmaceuticals USA | $93.97 | 2023-2025 | Ryaltris |
| Seqirus USA INC | $88.08 | 2025 | Fluad, Flucelvax |
| Corium, LLC | $68.62 | 2023-2025 | Azstarys |
| Esperion Therapeutics, INC. | $67.29 | 2021-2025 | Nexletol |
| Ironwood Pharmaceuticals, INC | $64.51 | 2021-2024 | Linzess |
| Azurity Pharmaceuticals, INC. | $55.80 | 2023 | Edarbi |
| Currax Pharmaceuticals LLC | $54.99 | 2021-2022 | |
| Adlon Therapeutics L.P. | $51.10 | 2021 | |
| Evoke Pharma, INC. | $50.31 | 2024-2025 | |
| Tris Pharma INC | $47.21 | 2023-2025 | Dyanavel Xr |
| Teva Pharmaceuticals USA, INC. | $40.55 | 2021-2023 | Austedo |
| Idorsia Pharmaceuticals US INC | $40.24 | 2023-2024 | Quviviq |
| Travere Therapeutics, INC. | $37.42 | 2025 | |
| Ibsa Pharma INC. | $35.22 | 2024-2025 | Tirosint, Licart, Flector |
| Eisai INC. | $31.98 | 2021-2022 | |
| Genentech USA, INC. | $30.76 | 2021 | |
| Supernus Pharmaceuticals, INC. | $26.65 | 2021-2022 | Xyosted |
| Halozyme INC | $22.21 | 2023 | |
| Clarus Therapeutics INC. | $21.00 | 2021 | |
| Aimmune Therapeutics, INC. | $20.77 | 2025 | Zenpep |
| Cranial Technologies, INC | $19.02 | 2025 | Doc Band |
| Boston Scientific Corporation | $17.54 | 2024 | |
| Harmony Biosciences LLC | $14.54 | 2021 | |
| Acella Pharmaceuticals, LLC | $13.56 | 2025 | NP Thyroid 60 |
| Vivaquant INC, Dba Rhythm Express | $13.29 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.